Jacobs Levy Equity Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-133,658	Closed	-$172K	–	1130
2017 Q4	$172K	Buy	133,658 +42,119	+46%	+$54.2K	﹤0.01%	925
2017 Q3	$194K	Buy	+91,539	New	+$194K	﹤0.01%	870
2017 Q2	–	Sell	-24,100	Closed	-$83K	–	1098
2017 Q1	$83K	Buy	+24,100	New	+$83K	﹤0.01%	870